95 related articles for article (PubMed ID: 11978940)
1. Remission induction of refractory anaemia with excess blasts in transformation by sole treatment with granulocyte colony-stimulating factor with persistent chromosomal abnormality.
Kondo H; Kasahara Y; Mori A
Acta Haematol; 2002; 107(3):177-81. PubMed ID: 11978940
[TBL] [Abstract][Full Text] [Related]
2. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
3. [RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF].
Kaito K; Otsubo H; Ogasawara Y; Sekita T; Saeki A; Nishiwaki K; Masuoka H; Shimada T; Kobayashi M; Sakai O
Rinsho Ketsueki; 1995 Apr; 36(4):365-70. PubMed ID: 7540227
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of Vater.
Takahashi T; Kazama Y; Shimizu H; Yoshimoto M; Tsujisaki M; Aoki S; Imai K
Int J Hematol; 2001 Jul; 74(1):64-9. PubMed ID: 11530807
[TBL] [Abstract][Full Text] [Related]
5. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
[TBL] [Abstract][Full Text] [Related]
6. Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts.
Yokose N; Ogata K; An E; Tamura H; Kamikubo K; Dan K; Nomura T
Ann Hematol; 1995 Mar; 70(3):163-7. PubMed ID: 7536478
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
8. Marked and reproducible increase in trilineage blood cell counts by administration of granulocyte colony-stimulating factor in a patient with refractory anaemia with excess blasts in transformation.
Chiba S; Inamori K; Mitani K; Hirai H; Yazaki Y
Br J Haematol; 1994 Mar; 86(3):665-7. PubMed ID: 7519041
[TBL] [Abstract][Full Text] [Related]
9. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
[TBL] [Abstract][Full Text] [Related]
10. [A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].
Murate T; Ohashi H; Kagami Y; Hotta T; Murase T; Hirota Y; Kimura K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2155-8. PubMed ID: 1716093
[TBL] [Abstract][Full Text] [Related]
11. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
Maekawa T; Fujii H; Shizumi Y; Ebisui S; Horishi M; Suyama Y; Miyoshi M; Horiike S
Gan No Rinsho; 1988 Dec; 34(15):2109-13. PubMed ID: 3230641
[TBL] [Abstract][Full Text] [Related]
12. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
[TBL] [Abstract][Full Text] [Related]
13. Refractory anaemia with excess of blasts as a terminal evolution of paroxysmal nocturnal haemoglobinuria. A case report with chromosomal analysis.
Aymard JP; Buisine J; Grégoire MJ; Janot C; Streiff F
Acta Haematol; 1985; 74(3):181-3. PubMed ID: 3938165
[TBL] [Abstract][Full Text] [Related]
14. Complete remission in a patient with hypoplastic acute lymphoblastic leukemia induced by granulocyte-colony-stimulating factor.
Hatta Y; Iwata T; Takeuchi J; Ohshima T; Horie T
Acta Haematol; 1995; 94(1):39-43. PubMed ID: 7544523
[TBL] [Abstract][Full Text] [Related]
15. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of infections in a case with myelodysplastic syndrome by an intermittent subcutaneous administration of G-CSF].
Saburi Y; Ohno E; Hirota K; Miyazaki Y; Gotoh T; Miyazaki S; Ohtsuka E; Kikuchi H; Nasu M; Tashiro T; Akiyama H
Kansenshogaku Zasshi; 1996 May; 70(5):506-11. PubMed ID: 8699101
[TBL] [Abstract][Full Text] [Related]
17. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
18. Duplication of 1q in a child with down syndrome and myelodysplastic syndrome.
Blann MM; Morgan DL; Oblender M; Heinen B; Williams J; Tonk VS
Cancer Genet Cytogenet; 2000 May; 119(1):74-6. PubMed ID: 10812176
[TBL] [Abstract][Full Text] [Related]
19. Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
Ferrara F; Schiavone EM; Palmieri S; Mele G; Pocali B; Scalia G; Morabito P; Sebastio L; Del Vecchio L
Hematol J; 2003; 4(3):218-21. PubMed ID: 12764355
[TBL] [Abstract][Full Text] [Related]
20. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
Saito K; Nakamura Y; Aoyagi M; Waga K; Yamamoto K; Aoyagi A; Inoue F; Nakamura Y; Arai Y; Tadokoro J; Handa T; Tsurumi S; Arai H; Kawagoe Y; Gunnji H; Kitsukawa Y; Takahashi W; Furusawa S
Int J Hematol; 2000 Apr; 71(3):238-44. PubMed ID: 10846828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
